Does Geisinger Health Plan Cover Ozempic?
The verdict
Conditional on most plans
Geisinger Health Plan covers Ozempic for type 2 diabetes with prior authorization. Despite Geisinger's corporate parent being Risant Health (owned by Kaiser Permanente), Geisinger Health Plan operates its own formulary independently — Kaiser Northwest's metformin plus SGLT-2 step-therapy requirement is Kaiser-specific and does not govern Geisinger Health Plan PA. Off-label weight-loss use is not covered under any Geisinger Health Plan line of business. Formulary details are not publicly confirmed at the drug level — verify on Geisinger Health Plan's drug lookup.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Geisinger Health Plan using your member ID.
Key facts
Geisinger Health Plan is owned by Risant Health (a Kaiser Permanente subsidiary) but maintains its own independent formulary — Kaiser Northwest's SGLT-2 step-therapy requirement for Ozempic does not apply to Geisinger Health Plan.
Geisinger Health System / Risant Health corporate announcements
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D adults — not for weight loss. Off-label weight-loss use is not covered under any health plan.
FDA drug labeling, Ozempic (semaglutide injection)
The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) under Medicare is $274 per 30-day supply, effective January 1, 2027.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Geisinger Health Plan covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (Geisinger Gold): Ozempic is covered for type 2 diabetes with prior authorization. PA requires a documented T2D diagnosis and metformin step-therapy (or documented intolerance/contraindication). The 2026 Part D $2,100 out-of-pocket cap limits annual beneficiary exposure. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply effective January 1, 2027. Medicare Advantage enrollees cannot use the NovoCare savings card (federal anti-kickback rules). Ozempic is not covered for weight loss on any Geisinger Gold plan.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Geisinger Health Plan covers Ozempic for type 2 diabetes with prior authorization and standard metformin step-therapy. Formulary tier and copay details are not publicly confirmed at the drug level — verify on Geisinger Health Plan's drug lookup. The plan operates its own PA criteria independently of Kaiser Permanente's formulary. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150/28-day supply); not available to Medicare Advantage or Medicaid enrollees. ACA/Individual: covered for T2D with PA; not covered for weight loss. Medicaid (Geisinger Health Plan Community Care): covered for T2D with PA and nominal Medicaid cost-share; not covered for off-label weight loss.
The 2 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 2 requirements selected. Meet all 2 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing). NovoCare self-pay: ~$199/month intro (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial/Employer: tier-based cost-share; specific tier not publicly published — verify on Geisinger Health Plan's drug lookup. Medicare Advantage (Geisinger Gold): cost-share per plan design; $2,100 OOP cap 2026; IRA Maximum Fair Price $274/30-day effective January 1, 2027. Medicaid (Community Care): nominal $0–$4 typical.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare Advantage, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Specific tier and cost-share for Geisinger Health Plan commercial and Medicare plans are not publicly published at the drug level. Verify on Geisinger Health Plan's drug lookup or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use Geisinger Health Plan's drug lookup to confirm formulary status and PA requirements
Visit geisinger.org and use the plan's formulary or drug-lookup tool with your member ID to confirm Ozempic's tier, any prior-authorization requirements, and step-therapy criteria specific to your commercial, Geisinger Gold, or Community Care plan. Geisinger Health Plan's PA criteria are separate from Kaiser Permanente's — verify on Geisinger's own portal.
- 2
Have your prescriber submit the prior authorization for type 2 diabetes
The PA requires a documented T2D diagnosis (ICD-10 E11.x) and evidence of metformin use (or a documented reason metformin is contraindicated or not tolerated). The clinical indication must be type 2 diabetes; a weight-management indication will not support PA approval. PA criteria are not identical to Kaiser NW's — Geisinger Health Plan does not require an SGLT-2 inhibitor step, though you should confirm directly.
- 3
Check NovoCare savings card eligibility if you have commercial coverage
If you have a Geisinger Health Plan commercial or employer-sponsored plan and a confirmed T2D diagnosis, visit NovoCare.com to enroll in the Ozempic Savings Card, which may reduce your out-of-pocket cost to as little as $25 per fill (max $150/28-day supply). This card is not available to Geisinger Gold (Medicare Advantage) or Community Care (Medicaid) enrollees.
Options if Geisinger Health Plan won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet approved for type 2 diabetes. Covered for T2D with PA on most plans; also subject to the IRA Maximum Fair Price of $274/30-day for Medicare patients effective January 1, 2027. Verify tier on Geisinger Health Plan's drug lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as oral step therapy before Ozempic PA. Note: Geisinger Health Plan does not appear to require an SGLT-2 step as a PA condition (unlike Kaiser NW), but an SGLT-2 inhibitor may still be a lower-cost T2D treatment option. Verify on formulary.
Wegovy (semaglutide 2.4 mg)
On-label for weight management. Geisinger Health Plan's weight-loss GLP-1 coverage is not publicly confirmed in detail — employer-plan dependent. These are different drugs for coverage purposes; Ozempic T2D coverage is handled on a separate formulary pathway.
Compounded semaglutide (weight-loss seekers only)
For patients seeking semaglutide for weight management who are denied under Geisinger Health Plan, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
No. Geisinger Health Plan does not cover Ozempic for weight loss under any plan design. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction in T2D patients with known heart disease — not for weight management. Off-label weight-loss use is not a covered indication. If weight management is the goal, Wegovy is the on-label option, and its coverage at Geisinger Health Plan is not publicly confirmed for commercial plans.
No. Although Geisinger Health Plan is now a Risant Health subsidiary (owned by Kaiser Permanente), it operates its own independent formulary and PA criteria. Kaiser Northwest's requirement for a maximum-tolerated metformin dose plus an SGLT-2 inhibitor trial is Kaiser-specific and does not apply to Geisinger Health Plan. Geisinger Health Plan patients should verify their own plan's PA criteria directly with Geisinger, not assume Kaiser's rules apply.
Yes. Geisinger Health Plan covers Ozempic for type 2 diabetes with prior authorization across its commercial, Geisinger Gold (Medicare Advantage), and Community Care (Medicaid) lines. PA requires a documented T2D diagnosis and evidence of metformin step-therapy. Formulary tier and copay are not publicly confirmed at the drug level — verify on Geisinger Health Plan's drug lookup or by calling member services.
Yes, if you have a Geisinger Health Plan commercial or employer-sponsored plan and a confirmed T2D diagnosis. The NovoCare Ozempic Savings Card may reduce your cost to as little as $25 per fill (max $150/28-day supply). The card is not available to Geisinger Gold (Medicare Advantage) or Community Care (Medicaid) enrollees — federal anti-kickback rules exclude government program beneficiaries. Verify at NovoCare.com before assuming the card applies.
Geisinger Gold is Geisinger Health Plan's Medicare Advantage product. Ozempic is covered for type 2 diabetes with prior authorization under Geisinger Gold. The 2026 Part D $2,100 out-of-pocket cap limits annual exposure, and the IRA Maximum Fair Price for semaglutide drops to $274 per 30-day supply on January 1, 2027. Medicare Advantage enrollees cannot use the NovoCare savings card. Ozempic is not covered for weight loss on any Geisinger Gold plan.
Related Articles
Does Geisinger Health Plan Cover Mounjaro? 2026 Guide | Curex
Geisinger covers Mounjaro for type 2 diabetes with prior auth — not weight loss. PA Medicaid is diabetes-only after the 2025 weight-loss GLP-1 cut.
Read moreDoes Geisinger Health Plan Cover Wegovy? 2026 | Curex
Geisinger Wegovy coverage is employer-dependent and unpublished. PA Medicaid dropped GLP-1 obesity coverage in 2026. How to verify.
Read moreDoes UPMC Health Plan Cover Ozempic? 2026 Guide | Curex
UPMC Health Plan covers Ozempic for T2D with prior auth — PA may reflect UPMC clinical protocols. Weight-loss excluded. Formulary, PA steps, 2026 costs.
Read moreDoes Harvard Pilgrim Health Care Cover Mounjaro? 2026 | Curex
Harvard Pilgrim (Point32Health) covers Mounjaro for type 2 diabetes with PA — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes Health Net Cover Mounjaro? California 2026 | Curex
Health Net (Centene, CA) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Medi-Cal excludes weight-loss GLP-1s from 1/1/2026.
Read moreDoes Group Health Cooperative Cover Mounjaro? 2026 | Curex
Group Health Cooperative (GHC, WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite; verify on plan formulary.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
You just saw how tangled Ozempic coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Ozempic. No insurance or prior authorization required; prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Geisinger Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.